循环肿瘤细胞 (CTC) 诊断市场预计将从 2021 年的 19.0941 亿美元增至 2028 年的 36.5638 亿美元;预计 2021 年至 2028 年复合年增长率为 9.7%。
循环肿瘤细胞 (CTC) 在诊断和治疗癌症方面具有巨大潜力。许多技术已经开发出来并正在不断改进,以提高 CTC 检测、分离、富集和分析的功效。 CTC 检测和分离最常用的方法是基于免疫的检测,即抗体选择性结合细胞表面抗原。肿瘤细胞表达与血细胞不同的细胞表面标志物,并且与循环细胞分离。 CTC 有助于检测原发组织中存在的少量细胞亚群,这可能最终导致治疗抵抗或疾病复发。因此,检测和表征 CTC 可能成为治疗实体瘤恶性肿瘤的必然步骤。
战略见解
< p>循环肿瘤细胞 (CTC) 诊断市场根据技术、应用、最终用户和地理位置进行细分。按地理位置划分,市场大致分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。该报告提供了对市场的见解和深入分析,强调市场趋势、技术进步和市场动态等参数,以及对全球领先市场参与者的竞争格局的分析。 循环肿瘤细胞(CTC)诊断市场的利润丰厚的区域
市场洞察
对微创诊断程序的需求不断增长,以推动预测期内循环肿瘤细胞 (CTC) 诊断市场的增长
人们越来越偏爱微创诊断程序出于诊断目的对患者进行微创或无创手术。使用循环肿瘤细胞诊断(采用非侵入性方法)可以实现早期癌症检测、突变检测、整个治疗过程中的肿瘤监测以及复发监测。研究人员可以使用含有循环肿瘤细胞的血液样本追踪实体瘤中的所有表观遗传和遗传变化。通过这些测试,患者面临的风险较小,临床医生可以轻松地多次进行这些测试。患者更喜欢微创手术,因为此类手术中使用的先进仪器可以以更低的风险、更少的疼痛和更少的疤痕进行更精细和复杂的工作。
由于可行性和处理时间方面的技术进步循环肿瘤细胞诊断和液体活检作为癌症患者组织活检的非侵入性替代方法最近引起了人们的极大兴趣。对改进的微创癌症检测技术的进一步了解将有助于液体活检的采用。市场增长将受到对非侵入性工具的需求不断增长以及实验室对 CTC 测试和液体活检的接受程度的影响。液体活检是手术活检的一种无创且简单的替代方案,使医生能够从简单的血液样本中发现有关肿瘤的一系列信息。血液检查无痛、无创、无风险,并且减少了诊断问题的成本和时间。此外,还可以在血液样本中检测到 CTC、cfDNA、外泌体和微泡,这使得基于血液的液体活检更加流行。因此,对微创诊断测试的需求增加正在刺激市场增长。
技术洞察
根据技术,全球循环肿瘤细胞(CTC)诊断市场分为CTC检测和富集方法、CTC直接检测方法和CTC分析。 2020年,CTC检测和富集领域占据了最大的市场份额。此外,预计同一细分市场在 2021 年至 2028 年期间将实现最高的复合年增长率。在 CTC 诊断的帮助下,个体可以得到早期诊断。因此,这些技术的应用正在增加,预计将在预测期内推动市场。
应用洞察
根据应用,全球循环肿瘤细胞(CTC)诊断市场分为临床/液体活检和研究。 2020 年,研究领域占据了更大的市场份额,预计该领域在 2021 年至 2028 年的市场复合年增长率将更高。由于全球范围内各种医疗状况检测和诊断的增加,预计未来市场将会增长。
完-用户洞察
根据最终用户,循环肿瘤细胞(CTC)诊断市场分为医院和诊所、研究和学术机构以及诊断中心。研究和学术机构细分市场在 2021 年占据最大的市场份额,预计在预测期内将实现最高的复合年增长率。对癌症诊断和治疗开发的研究不断增加、人们对癌症诊断的认识不断提高以及政府和其他企业的高投资是支持研究和学术机构领域市场增长的一些关键因素。
按技术划分的循环肿瘤细胞 (CTC) 诊断市场 – 2021年和2028年
产品上市、并购是全球循环肿瘤细胞(CTC)高度采用的策略)诊断市场参与者。下面列出了近期的一些关键市场动态:
- 2022 年 1 月,赛默飞世尔科技公司 (Thermo Fisher Scientific Inc.) 宣布以现金总价约 100 美元彻底收购 PeproTech。 18.5 亿美元。
- 2021 年 12 月,Epic Sciences, Inc. 宣布推出 DefineMBC,这是一种新型转移性乳腺癌 (MBC) 测试,包括基于细胞和无细胞的单一分析抽血。
COVID-19 大流行对癌症患者和癌症监测能力产生了负面影响。此外,由于大流行,资源和护理可用性的减少使得癌症检测和治疗变得困难,导致死亡率更高和生存率更低。由于癌症和/或其治疗引起的免疫系统受损,癌症患者容易受到传染性病原体(例如手术和化疗)的影响。这引起了人们的担忧,即癌症患者中可能存在常见的 COVID-19 问题和死亡。因此,疫情对循环肿瘤细胞 (CTC) 诊断市场产生了负面影响。
循环肿瘤细胞 (CTC) 诊断 –市场细分
全球循环肿瘤细胞 (CTC) 诊断市场根据技术、应用、最终用户和地理位置进行细分。从技术角度来看,市场分为CTC检测和富集方法、CTC直接检测方法和CTC分析。根据应用,全球循环肿瘤细胞(CTC)诊断市场分为临床/液体活检和研究。根据最终用户,循环肿瘤细胞(CTC)诊断市场分为医院和诊所、研究和学术机构以及诊断中心。按地理位置划分,市场大致分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美洲和中美洲。
公司简介
- Thermo Fisher Scientific Inc.
- STEMCELL Technologies Inc.
- QIAGEN
- Precision Medicine Group, LLC.
- Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)
- Epic科学
- ScreenCell
- Ikonisys, Inc.
- IVDiagnostics
- Fluxion Biosciences Inc0
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Global circulating tumor cell (CTC) diagnostics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The market growth in the country is attributed to the factors such as most foreign companies in the healthcare sector have R&D centres in the United States. Moreover, the increase in prevalence of cancer in the country along with various organic and inorganic developments done by the companies. And, Asia Pacific is the fastest-growing region growing at the CAGR of 10.3% during the forecast period.
The circulating tumor cell (CTC) diagnostics market majorly consists of the players such as Thermo Fisher Scientific, Stemcell Technologies, Inc, QIAGEN, Precision Medicine Group, LLC, Advanced Cell Diagnostics (Bio-Techne Corporation), Epic Lifesciences, Screencell, Ikonisys, Inc, IV Diagnostics, Fluxion Biosciences, among others
The research segment dominated the global circulating tumor cell (CTC) diagnostics market and accounted for the largest revenue share of 67.65% in 2021.
The CTC detection and enrichment method segment dominated the global circulating tumor cell (CTC) diagnostics market and held the largest revenue share of 62.85% in 2021.
Key factors that are driving the growth of this market are increasing prevalence of cancer across the globe along with rising demand for minimally invasive diagnostic procedures.
A Circulating Tumor Cell (CTC) is a cell that shed into lymphatics from the primary tumor and carried out throughout the body with blood circulation. Circulating tumor cells are the seeds for growth and metastases for additional tumors in distant organs and is responsible for majority of cancer related deaths. The diagnosis, detection and analysis of CTC can assist in patients’ prognoses determine appropriate tailored treatments for the patients. The CTC diagnosis has a lot of advantages for traditional diagnostic procedures. The advantages of CTC detection include, it is non-invasive, effective and can be used repeatedly. The CTC detection and enrichment, CTC direct detection and CTC analysis are the technologies used for CTC detection.
The List of Companies - Circulating Tumor Cell (CTC) Diagnostics Market
- Thermo Fisher Scientific Inc.
- STEMCELL Technologies Inc.
- QIAGEN
- Precision Medicine Group, LLC.
- Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)
- Epic Sciences
- ScreenCell
- Ikonisys, Inc.
- IVDiagnostics
- Fluxion Biosciences Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jan 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jan 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jan 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jan 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)